- $64.01m
- $32.46m
- $30.26m
Forian Inc reports results for the quarter ended in June - Earnings Summary
Brief: Forian Inc. Q2 revenue USD 4.9 million
Forian Inc expected to post a loss of 5 cents a share - Earnings Preview
Forian Inc reports results for the quarter ended in March - Earnings Summary
Brief: Forian Inc Posts Q1 EPS $0.19
Forian Inc expected to post a loss of 11 cents a share - Earnings Preview
Forian Inc reports results for the quarter ended in December - Earnings Summary
Forian Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Forian Announces The Sale Of Biotrack To Alleaves
Brief: New York Selects Biotrack As The State's Cannabis Track And Trace System
Brief: Forian Inc Announces Third Quarter 2022 Financial Results
Brief: Forian Q2 Revenue $6.5 Million
Brief: Forian Announces Fourth Quarter And Full Year 2021 Financial Results
Brief: Florida Chooses Biotrack As The State's Cannabis Track And Trace System
Brief: Forian Inc. Announces $24 Million Private Placement Of 3.5% Convertible Notes Due 2025, Appoints New Chief Financial Officer
Brief: Forian Inc. Announces Second Quarter Fiscal 2021 Financial Results
Brief: Forian Inc - Q1 Loss Per Share Of $0.19
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:05 AM